Gut Microbes

Article	Citations
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	241
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	209
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	203
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	194
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	160
Modeling spatial interaction networks of the gut microbiota	149
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	140
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	114
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	114
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	104
Effect of diet on the evolution of gut commensal bacteria	101
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	94
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	93
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	93
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	91
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	89
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	86
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	86
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	81
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	79
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	76
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	75
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	73
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	73
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	73

Intestinal bacteria and colorectal cancer: etiology and treatment	72
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	72
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	70
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	69
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	69
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	68
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	67
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	67
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	67
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	66
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	65
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	65
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	65
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	62
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	62
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	60
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	60
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	60
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	60
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	59
Engineered bacteria as an orally administered anti-viral treatment and immunization system	59
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	58
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	57
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	57
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	56
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	56
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	56
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism	55
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease	55
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	54
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	54
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	54
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	54
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	53
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	53
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	53
Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design	53
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	53
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	52
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection	52
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	52
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	51
Akkermansia in the gastrointestinal tract as a modifier of human health	51
Role of gut microbes in acute lung injury/acute respiratory distress syndrome	51
Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies	50
Entamoeba muris mitigates metabolic consequences of high-fat diet in mice	50
Comprehensive assessment of machine learning methods for diagnosing gastrointestinal diseases through whole metagenome sequencing data	50
Alterations in mucosa branched N -glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation	47
Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “Gut-Immune-Bone” axis	47
Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward	47

The transplantation of the gut microbiome of fat-1 mice protects against colonic mucus layer disruption and endoplasmic reticulum stress induced by high fat diet	47
Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis	46
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	46
Quorum sensing modulates bacterial virulence and colonization dynamics of the gastrointestinal pathogen Citrobacter rodentium	46
The multifaceted virulence of adherent-invasive Escherichia coli	46
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights	46
Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan	46
Why are so many enteric pathogen infections asymptomatic? Pathogen and gut microbiome characteristics associated with diarrhea symptoms and carriage of diarrheagenic E. coli	46
Intestinal deguelin drives resistance to acetaminophen-induced hepatotoxicity in female mice	45
Integrative analysis with microbial modelling and machine learning uncovers potential alleviators for ulcerative colitis	45
Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carriage and non-CDI d	45
CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA	44
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain	44
Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus -associated host cognitive impairment	44
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bi	43
CobB-mediated deacetylation of the chaperone CesA regulates Escherichia coli O157:H7 virulence	43
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?	43
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content	43
Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide	42
Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy	42
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	42
The human gut microbiome and aging	41
Salmonella utilizes L-arabinose to silence virulence gene expression for accelerated pathogen growth within the host	41
PUFAs add fuel to Crohn’s disease-associated AIEC-induced enteritis by exacerbating intestinal epithelial lipid peroxidation	41
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion	41
Lactic acid bacteria and bifidobacteria deliberately introduced into the agro-food chain do not significantly increase the antimicrobial resistance gene pool	41
Exploring substrate–microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions	41
Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway	41
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis	41
Human milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms	41
Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor	41
Membrane protective role of autophagic machinery during infection of epithelial cells by Candida albicans	40
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma	40
Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model	40
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohort	40
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celi	40
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals	39
Fusobacterium nucleatum -driven CX3CR1 + PD-L1 + phagocytes route to tumor tissues and reshape tumor microenvir	39
Microbiome’s role in musculoskeletal health through the gut-bone axis insights	39
PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression	39
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma	39
The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC	39
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms	39
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use	38
Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria	38
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease	38
Gut microbiome at the crossroad of genetic variants and behavior disorders	37
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease	37
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	37
Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavioral and neuroendocrine changes in a nonhuman primate model	37
Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota	37
Enterohemorrhagic Escherichia coli responds to gut microbiota metabolites by altering metabolism and activating stress responses	36
Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella -induced arthritis	36
From a hunger-regulating hormone to an antimicrobial peptide: gastrointestinal derived circulating endocrine hormone-peptide YY exerts exocrine antimicrobial effects against selective gut microbiota	36
Akkermansia muciniphila : a deworming partner independent of type 2 immunity	35
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data	35
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	35
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes	35
Magnetic chitin beads (MCB) coated with Vibrio cholerae reveals transcriptome dynamics in adult mice with a complex gut microbiota	35
Infant gut microbiota restoration: state of the art	35
Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis	34
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases	34
High variation across E. coli hybrid isolates identified in metabolism-related biological pathways co-expressed with virulent genes	34
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion	34
Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis	33
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis	33
Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa	33
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity	33
Using a human colonoid-derived monolayer to study bacteriophage translocation	33
Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection	32
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics	32
IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation	32
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease	32
Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis	32
Mouse strain-specific responses along the gut-brain axis upon fecal microbiota transplantation from children with autism	32
Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a post-hoc analysis of a randomized clinical trial	32
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation	31
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response	31
Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD	31
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention	31

Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis	31
Fabry disease – a multisystemic disease with gastrointestinal manifestations	31
The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk	31
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	31
Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites	31
Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn’s disease	31
Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice	30
Alcaligenes faecalis promotes colitis to colorectal cancer transition through IgA+ B cell suppression and vinculin acetylation	30
Maternal-infant probiotic transmission mitigates early-life stress-induced autism in mice	30
The hidden base of the iceberg: gut peptidoglycome dynamics is foundational to its influence on the host	30
Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis	30
The interplay between PCOS pathology and diet on gut microbiota in a mouse model	30
ZntA maintains zinc and cadmium homeostasis and promotes oxidative stress resistance and virulence in Vibrio parahaemolyticus	30
Diet-induced shifts in the gut microbiota influence anastomotic healing in a murine model of colonic surgery	30
M28 family peptidase derived from Peribacillus frigoritolerans initiates trained immunity to prevent MRSA via the complosome-phosphatidylcholine axis	30
The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia	30
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease	30
Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model mice	30
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats	30
Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes	30
Integrated analysis of gut metabolome, microbiome, and brain function reveal the role of gut-brain axis in longevity	30
Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic	30
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes	30
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial	29
Primers matter: Influence of the primer selection on human fungal detection using high throughput sequencing	29
Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces	29
Neonatal necrotizing enterocolitis: Clostridium butyricum and Clostridium neonatale fermentation metabolism and enteropathogenicity	29
Diet standardization reduces intra-individual microbiome variation	29
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis	29
Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection	29
The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging	29
Fucose promotes intestinal stem cell-mediated intestinal epithelial development through promoting Akkermansia -related propanoate metabolism	29
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice	29
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project	29
Actively replicating gut bacteria identified by 5-ethynyl-2’-deoxyuridine (EdU) click chemistry and cell sorting	29
DSS treatment does not affect murine colonic microbiota in absence of the host	29
The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging – relevant neural and immune function	29
Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction	28
Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin	28
Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair	28
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure	28
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health	28
Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis	28
Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation	28
Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota	28
Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation	27
Psyllium fiber protects mice against western diet-induced metabolic syndrome via the gut microbiota-dependent mechanism	27
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies	27
Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles	27
Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection	27
Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics	27
Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway	26
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions	26
Better together– Salmonella biofilm-associated antibiotic resistance	26
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications	26
Gut microbiome in healthy aging versus those associated with frailty	26
Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice	25
Preterm infants at low risk for early-onset sepsis differ in early fecal microbiome assembly	25
Muropeptides and muropeptide transporters impact on host immune response	25
A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model	25
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma	25
Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury	25
Dietary S. maltophilia induces supersized lipid droplets by enhancing lipogenesis and ER-LD contacts in C. elegans	25
Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats	25
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota	25
Bifidobacterium inhibits the progression of colorectal tumorigenesis in mice through fatty acid isomerization and gut microbiota modulation	24
Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomye	24
Genetic variation in gut microbe as a key regulator of host social behavior in C. elegans	24
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes	24
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients	24
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma	24
Metagenomic source tracking after microbiota transplant therapy	24
Parity modulates impact of BMI and gestational weight gain on gut microbiota in human pregnancy	24
Abnormalities in gut virome signatures linked with cognitive impairment in older adults	24
Methodological challenges in neonatal microbiome research	24
Hydrogen peroxide in breast milk is crucial for gut microbiota formation and myelin development in neonatal mice	24
Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation	23
Effects of Prevotella copri on insulin, gut microbiota and bile acids	23
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus	23
New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation	23
Mucus, commensals, and the immune system	23
How longitudinal data can contribute to our understanding of host genetic effects on the gut microbiome	23
Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response	22
The effects of gut microbiota on appetite regulation and the underlying mechanisms	22
The role of the early-life gut microbiome in childhood asthma	22
mNFE: microbiome network flow entropy for detecting pre-disease states of type 1 diabetes	22
The human gut serves as a reservoir of hypervirulent Klebsiella pneumoniae	22
Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions	22
Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?	22
Transcriptional profiling of zebrafish intestines identifies macrophages as host cells for human norovirus infection	22
The early life exposome and autism risk: a role for the maternal microbiome?	22
The influence of the gut microbiome on ovarian aging	22
Segmental patterning of microbiota and immune cells in the murine intestinal tract	22
Correction	22
Intracellular glycogen accumulation by human gut commensals as a niche adaptation trait	22